WO2000070017A3 - Methods using of fab i and compounds modulating fab i activity - Google Patents
Methods using of fab i and compounds modulating fab i activity Download PDFInfo
- Publication number
- WO2000070017A3 WO2000070017A3 PCT/US2000/012104 US0012104W WO0070017A3 WO 2000070017 A3 WO2000070017 A3 WO 2000070017A3 US 0012104 W US0012104 W US 0012104W WO 0070017 A3 WO0070017 A3 WO 0070017A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fab
- disclosed
- methods
- polypeptides
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000618423A JP2002544291A (en) | 1999-05-14 | 2000-05-04 | How to use FABI |
EP00935862A EP1180164A4 (en) | 1999-05-14 | 2000-05-04 | Methods using of fab i and compounds modulating fab i activity |
US10/888,524 US20050112713A1 (en) | 1996-08-28 | 2004-07-09 | Methods of using Fab I and compounds modulating Fab I activity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13436299P | 1999-05-14 | 1999-05-14 | |
US60/134,362 | 1999-05-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/888,524 Continuation-In-Part US20050112713A1 (en) | 1996-08-28 | 2004-07-09 | Methods of using Fab I and compounds modulating Fab I activity |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000070017A2 WO2000070017A2 (en) | 2000-11-23 |
WO2000070017A3 true WO2000070017A3 (en) | 2001-02-08 |
Family
ID=22463029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/012104 WO2000070017A2 (en) | 1996-08-28 | 2000-05-04 | Methods using of fab i and compounds modulating fab i activity |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1180164A4 (en) |
JP (1) | JP2002544291A (en) |
WO (1) | WO2000070017A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6010881A (en) | 1996-02-20 | 2000-01-04 | Smithkline Beecham Corporation | RibG |
EP0956289A4 (en) | 1996-08-16 | 2004-10-13 | Smithkline Beecham Corp | Novel prokaryotic polynucleotides, polypeptides and their uses |
US6995254B1 (en) | 1996-08-28 | 2006-02-07 | Affinium Pharmaceuticals, Inc. | Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB I |
US6951729B1 (en) | 1999-10-27 | 2005-10-04 | Affinium Pharmaceuticals, Inc. | High throughput screening method for biological agents affecting fatty acid biosynthesis |
US7048926B2 (en) | 2000-10-06 | 2006-05-23 | Affinium Pharmaceuticals, Inc. | Methods of agonizing and antagonizing FabK |
EP1648928A2 (en) | 2003-07-11 | 2006-04-26 | Affinium Pharmaceuticals, Inc. | Novel purified polypeptides from staphylococcus aureus |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0826774A2 (en) * | 1996-08-28 | 1998-03-04 | Smithkline Beecham Corporation | Staphylococcal Fab I enoyl-ACP reductase |
-
2000
- 2000-05-04 JP JP2000618423A patent/JP2002544291A/en active Pending
- 2000-05-04 WO PCT/US2000/012104 patent/WO2000070017A2/en not_active Application Discontinuation
- 2000-05-04 EP EP00935862A patent/EP1180164A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0826774A2 (en) * | 1996-08-28 | 1998-03-04 | Smithkline Beecham Corporation | Staphylococcal Fab I enoyl-ACP reductase |
JPH10174590A (en) * | 1996-08-28 | 1998-06-30 | Smithkline Beecham Corp | Fab i |
Non-Patent Citations (2)
Title |
---|
BERGLER H. ET AL.: "Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of escherichia coli", J. BIOL. CHEM., vol. 269, no. 8, 25 February 1994 (1994-02-25), pages 5493 - 5496, XP002933508 * |
See also references of EP1180164A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP1180164A4 (en) | 2002-11-27 |
EP1180164A2 (en) | 2002-02-20 |
JP2002544291A (en) | 2002-12-24 |
WO2000070017A2 (en) | 2000-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0837131A3 (en) | Staphylococcus fibronectin binding protein compounds | |
EP0837138A3 (en) | Novel topoisomerase III | |
WO2001034809A3 (en) | Staphylococcus epidermidis nucleic acids and proteins | |
AU1724795A (en) | Human tissue inhibitor of metalloproteinase-4 | |
EP0826774A3 (en) | Staphylococcal Fab I enoyl-ACP reductase | |
EP0837130A3 (en) | M protein analogue from Streptococcus pneumoniae | |
WO2003080856A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP0837137A3 (en) | Novel topoisomerase III | |
EP0834568A3 (en) | Novel saliva binding protein | |
EP0835938A3 (en) | Topoisomerase I | |
WO2000070017A3 (en) | Methods using of fab i and compounds modulating fab i activity | |
EP0837136A3 (en) | Novel topoisomerase I | |
EP0845535A3 (en) | Leader peptidase (lep) from Streptococcus | |
WO2001029217A3 (en) | Novel polypeptides and polynucleotides encoding same | |
EP0843016A3 (en) | Staphylococcus FabD (malonylCoA:ACP transacylase) protein | |
WO2003029423A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP0808899A3 (en) | Human marco scavenger receptor (HMarcoSR) | |
WO2001064876A3 (en) | Human schizophrenia gene | |
EP0843011A3 (en) | RsbU-1 derived from Staphylococcus | |
EP0839910A3 (en) | Spo-rel, a Staphylococcus relA/spot homologue | |
EP0845531A3 (en) | Polypeptides and polynucleotides from the Staphylococcus SigB operon | |
EP0846766A3 (en) | IgA Fc binding protein from Streptococcus pneumoniae | |
EP0838523A3 (en) | RsbW-1 derived from Staphylococcus | |
EP0816502A3 (en) | Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae | |
EP0838524A3 (en) | RsbV-1 derived from Staphylococcus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10009219 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000935862 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 618423 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000935862 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000935862 Country of ref document: EP |